Allchem Lifescience IPO is a Book Building IPO listing on BSE,NSE exchange. The company is based in Vadodara and caters to Pharmaceutical sector. Emkay Global Financial Services is the merchant banker of Allchem Lifescience IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 13th March 2025.
Allchem Lifescience IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].Allchem Lifescience IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Emkay Global Financial Services Limited is the book-running lead manager of the Allchem Lifescience IPO. MUFG Intime India Private Limited is the Registrar for Allchem Lifescience IPO.
Allchem Lifescience IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Allchem Lifescience IPO, based in Vadodara, operates in the Pharmaceutical sector with a focus on Manufacturer of active pharmaceutical ingredients (API) intermediates. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Allchem Lifescience IPO size is ₹ [●] with fresh issue size of ₹ [●] and Offer for sale being ₹ Nil.
The IPO allotment date for Allchem Lifescience IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Allchem Lifescience IPO allotment status on the registrars website, MUFG Intime India Private Limited. Allchem Lifescience IPO refund dates are [●].
Allchem Lifescience IPO is expected to be listed on [●].
The upper price band for the Allchem Lifescience IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Allchem Lifescience IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Allchem Lifescience IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Allchem Lifescience IPO is finalised.
The merchant banker for Allchem Lifescience IPO is Emkay Global Financial Services Limited . Emkay Global Financial Services Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Allchem Lifescience IPO RHP for further details.
The registrar for Allchem Lifescience IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Allchem Lifescience IPO through their official website or helpline.
Allchem Lifescience IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Allchem Lifescience IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Allchem Lifescience Financial Review Page
Merchant Banker(s) of Allchem Lifescience IPO: Emkay Global Financial Services Limited
Allchem Lifescience IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Allchem Lifescience IPO listed at a listing price of against the offer price of .
The current market price of Allchem Lifescience is .
Why Us?